| Estimated global proportions of individuals with persistent fatigue, cognitive, and respiratory symptom clusters following symptomatic COVID-19 in 2020 and 2021 SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ... Jama 328 (16), 1604-1615, 2022 | 662 | 2022 |
| mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant H Gruell, K Vanshylla, P Tober-Lau, D Hillus, P Schommers, C Lehmann, ... Nature medicine 28 (3), 477-480, 2022 | 432 | 2022 |
| Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study D Hillus, T Schwarz, P Tober-Lau, K Vanshylla, H Hastor, C Thibeault, ... The Lancet Respiratory Medicine 9 (11), 1255-1265, 2021 | 376 | 2021 |
| Complement activation induces excessive T cell cytotoxicity in severe COVID-19 P Georg, R Astaburuaga-García, L Bonaguro, S Brumhard, L Michalick, ... Cell 185 (3), 493-512. e25, 2022 | 192 | 2022 |
| A global systematic analysis of the occurrence, severity, and recovery pattern of long COVID in 2020 and 2021 SW Hanson, C Abbafati, JG Aerts, Z Al-Aly, C Ashbaugh, T Ballouz, ... MedRxiv, 2022 | 87 | 2022 |
| Delayed antibody and T-cell response to BNT162b2 vaccination in the elderly, Germany T Schwarz, P Tober-Lau, D Hillus, ET Helbig, LJ Lippert, C Thibeault, ... Emerging Infectious Diseases 27 (8), 2174, 2021 | 83 | 2021 |
| Long-term immunogenicity of BNT162b2 vaccination in older people and younger health-care workers P Tober-Lau, T Schwarz, K Vanshylla, D Hillus, H Gruell, N Suttorp, ... The Lancet Respiratory Medicine 9 (11), e104-e105, 2021 | 80 | 2021 |
| Immunogenicity of COVID-19 tozinameran vaccination in patients on chronic dialysis E Schrezenmeier, L Bergfeld, D Hillus, JD Lippert, U Weber, P Tober-Lau, ... Frontiers in immunology 12, 690698, 2021 | 72 | 2021 |
| Neutralisation sensitivity of the SARS-CoV-2 omicron BA. 2.75 sublineage H Gruell, K Vanshylla, P Tober-Lau, D Hillus, LE Sander, F Kurth, F Klein The Lancet Infectious Diseases 22 (10), 1422-1423, 2022 | 35 | 2022 |
| Outbreak of SARS-CoV-2 B. 1.1. 7 lineage after vaccination in long-term care facility, Germany, February–March 2021 P Tober-Lau, T Schwarz, D Hillus, J Spieckermann, ET Helbig, LJ Lippert, ... Emerging Infectious Diseases 27 (8), 2169, 2021 | 26 | 2021 |
| Humoral immunity to SARS-CoV-2 elicited by combination COVID-19 vaccination regimens Z Wang, F Muecksch, F Muenn, A Cho, S Zong, R Raspe, V Ramos, ... Journal of Experimental Medicine 219 (10), e20220826, 2022 | 23 | 2022 |
| Impact of dexamethasone on SARS-CoV-2 concentration kinetics and antibody response in hospitalized COVID-19 patients: results from a prospective observational study B Mühlemann, C Thibeault, D Hillus, ET Helbig, LJ Lippert, P Tober-Lau, ... Clinical Microbiology and Infection 27 (10), 1520. e7-1520. e10, 2021 | 19 | 2021 |
| Characterization of antimicrobial use and co-infections among hospitalized patients with COVID-19: a prospective observational cohort study T Lingscheid, LJ Lippert, D Hillus, T Kruis, C Thibeault, ET Helbig, ... Infection 50 (6), 1441-1452, 2022 | 17 | 2022 |
| Cross-variant neutralizing serum activity after SARS-CoV-2 breakthrough infections P Tober-Lau, H Gruell, K Vanshylla, WM Koch, D Hillus, P Schommers, ... Emerging Infectious Diseases 28 (5), 1050, 2022 | 14 | 2022 |
| The life-saving benefit of dexamethasone in severe COVID-19 is linked to a reversal of monocyte dysregulation R Knoll, ET Helbig, K Dahm, O Bolaji, F Hamm, O Dietrich, M van Uelft, ... Cell 187 (16), 4318-4335. e20, 2024 | 7 | 2024 |
| Reactogenicity of homologous and heterologous prime-boost immunisation with BNT162b2 and ChAdOx1-nCoV19: a prospective cohort study D Hillus, P Tober-Lau, H Hastor, ET Helbig, LJ Lippert, C Thibeault, ... medRxiv, 2021 | 7 | 2021 |
| Impfungen als Schlüssel der Pandemiebewältigung NH Le, D Hillus, P Tober-Lau, LE Sander DMW-Deutsche Medizinische Wochenschrift 148 (24/25), 1557-1563, 2023 | 3 | 2023 |
| Interoperable, Domain-Specific Extensions for the German Corona Consensus (GECCO) COVID-19 Research Data Set Using an Interdisciplinary, Consensus-Based Workflow: Data Set … G Lichtner, T Haese, S Brose, L Röhrig, L Lysyakova, S Rudolph, M Uebe, ... JMIR Medical Informatics 11, e45496, 2023 | 3* | 2023 |
| Immunogenicity of COVID-19 tozinameran vaccination in patients on chronic dialysis. Front Immunol 12: 690698 E Schrezenmeier, L Bergfeld, D Hillus, JD Lippert, U Weber, P Tober-Lau, ... | 3 | 2021 |
| Short-and long-term T cell and antibody responses following dexamethasone treatment in COVID-19 C Thibeault, L Bardtke, K Vanshylla, V di Cristanziano, KA Eberhardt, ... JCI insight 8 (8), 2023 | 2 | 2023 |
